![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » IMI ANNOUNCES BOUGHT-DEAL PRIVATE PLACEMENT FINANCING
IMI ANNOUNCES BOUGHT-DEAL PRIVATE PLACEMENT FINANCING
August 22, 2005
Predictive medicine company IMI International Medical Innovations Inc. (TSX: IMI; Amex: IME) (the "Company" or "IMI") today announced it has entered into an engagement letter for a bought-deal private placement financing with a syndicate of underwriters led by Orion Securities Inc. and including Loewen Ondaatje McCutcheon Limited to issue CDN$10,000,000 (US$8,210,000) of units (the "Units") of the Company. Each Unit shall be comprised of a US$1,000 principal amount 7% convertible debenture (the "Debentures") and 157 common share purchase warrants (the "Warrants"), each convertible into one common share of the Company.
Canada NewsWire Group (http://www.newswire.ca/en/releases/archive/August2005/18/c1438.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct